Streetbeat News

Regulatory

BP

CVX

SHEL

XOM

Rep. Jamie Raskin criticized the petroleum industry for deceiving the public about climate change, hindering progress on addressing the crisis. During a Senate Budget Committee hearing, Raskin highlighted a report from a three-year investigation into the industry's evasion of climate responsibility, naming Exxon, Chevron, Shell, and BP among those obstructing the investigation. This comes as the world shifts away from fossil fuels, aiming for a 'net zero' carbon emissions target by 2050.

Portfolio Pulse from Benzinga Neuro

May 02, 2024 | 1:26 pm

IINN

Inspira Technologies OXY B.H.N. Ltd. (IINN) has announced the commencement of production for the INSPIRA ART100 medical device, which is being manufactured by a leading technology company. The first batch of devices will be deployed in initial sites pending FDA clearance.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 1:18 pm

NUWE

Nuwellis, Inc. (NASDAQ:NUWE) has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application related to its pediatric Continuous Renal Replacement Therapy (CRRT) device, Vivian™. This patent enhances Nuwellis' intellectual property portfolio and supports the development of technology aimed at improving treatment for critically ill children. The technology allows for seamless switching between stationary and mobile operation modes, enhancing patient mobility. The development of a new pediatric CRRT device is underway, funded partly by a $1.7 million NIH grant, in collaboration with Koronis Biomedical Technologies Corporation.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 1:02 pm

GOOGL

MSFT

An internal Microsoft email revealed concerns about lagging behind Google's AI capabilities, prompting investment in OpenAI. The email, part of a Justice Department antitrust case, highlights Microsoft's efforts to catch up in AI technology. Microsoft's CEO Satya Nadella emphasized the investment was aimed at broader innovation, not just search. The case sheds light on the competitive AI landscape, with Microsoft leveraging OpenAI's technology to enhance its products and Google facing challenges with its AI chatbot, Bard.

Portfolio Pulse from Ananya Gairola

May 02, 2024 | 12:53 pm

META

Meta Platforms (NASDAQ:META) reported better-than-expected Q1 earnings, with a 7% year-over-year increase in Family Daily Active People. The company anticipates higher capital spending to support its AI roadmap. The European Commission is investigating Meta's Facebook and Instagram for inadequate Russia disinformation moderation. Meta's dividend yield is 0.46%, requiring substantial investment for significant dividend income. Shares rose 2.1% to $439.19.

Portfolio Pulse from Avi Kapoor

May 02, 2024 | 12:52 pm

CB

Chubb (NYSE:CB) faces a record shipping insurance loss with a $350 million payout due to the Baltimore bridge collapse. This incident could lead to total insurance costs of $4 billion, marking a significant event in shipping insurance history. The collapse, caused by a Singapore-flagged container ship, has disrupted supply chains and prompted investigations into the ship's operations.

Portfolio Pulse from Benzinga Neuro

May 02, 2024 | 12:50 pm

IDCC

LNVGY

InterDigital was awarded an injunction against Lenovo by the Regional Court in Munich for infringing on a patent related to 4G and 5G devices. This legal victory emphasizes the strength of InterDigital's patent portfolio and its implications on Lenovo's operations in the relevant markets.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:37 pm

ESTA

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced the presentation of four-year results from the Motiva US IDE Study at The Aesthetic Meeting 2024. The study, which focuses on breast aesthetics and reconstruction, showed high patient compliance and low complication rates over four years. Dr. Caroline Glicksman presented the data, highlighting the consistency of clinical results and the potential for Motiva implants to set a new standard in breast implants in the U.S. The Motiva Implant PMA is currently under FDA review, with the implants not yet approved for commercial distribution in the United States.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:35 pm

SXTP

60 Degrees Pharmaceuticals has received feedback from the FDA regarding its clinical trial protocol for Tafenoquine-Babesiosis, indicating no material changes are required. This allows the trial planning and execution to proceed as planned.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:34 pm

IDCC

LNVGF

LNVGY

InterDigital was awarded an injunction against Lenovo by the Regional Court in Munich for infringing on a patent covering 4G and 5G devices. The court found InterDigital to have acted in a FRAND manner, while Lenovo was deemed an unwilling licensee not adhering to FRAND principles. This decision can be appealed.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:33 pm